| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Triazolam measurement |
Component |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing triazolam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam poisoning |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Accidental triazolam poisoning |
Causative agent (attribute) |
False |
Triazolam (substance) |
Inferred relationship |
Some |
|
| Intentional triazolam poisoning |
Causative agent (attribute) |
False |
Triazolam (substance) |
Inferred relationship |
Some |
|
| intoxication par le triazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam adverse reaction |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Allergy to triazolam (finding) |
Causative agent (attribute) |
False |
Triazolam (substance) |
Inferred relationship |
Some |
|
| Triazolam overdose |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Accidental triazolam overdose |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Intentional triazolam overdose |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| surdose de triazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triazolam 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triazolam (substance) |
Inferred relationship |
Some |
|
| Triazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triazolam (substance) |
Inferred relationship |
Some |
|
| Accidental triazolam poisoning |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Intentional triazolam poisoning |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Allergy to triazolam (finding) |
Causative agent (attribute) |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triazolam 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triazolam 125 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam 250 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely triazolam 125 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam 250 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Triazolam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
| Product containing only triazolam in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triazolam (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]